These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23825439)

  • 1. Hormone receptors and age distribution in breast cancer patients at a university hospital in northern egypt.
    Hussein O; Mosbah M; Farouk O; Farag K; El-Saed A; Arafa M; Abdallah A
    Breast Cancer (Auckl); 2013; 7():51-7. PubMed ID: 23825439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responding to the challenges of breast cancer in egypt and other arab countries.
    El Saghir NS
    J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
    Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
    BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
    Todorovic-Rakovic N; Neskovic-Konstantinovic Z
    J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of triple negative phenotype on breast cancer prognosis.
    Kaplan HG; Malmgren JA
    Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abstract PS6-55: The prognostic utility of AR/ER ratio in young women with breast cancer.
    Prabhu JS; Korlimarla A; Rajarajan S; Alexander A; Anupama C; Ramesh R; Srinath B; Sridhar TS
    Cancer Res; 2021 Feb; 81(4 Suppl):. PubMed ID: 34421401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer in women aging 35 years old and younger: The Egyptian National Cancer Institute (NCI) experience.
    Darwish AD; Helal AM; Aly El-Din NH; Solaiman LL; Amin A
    Breast; 2017 Feb; 31():1-8. PubMed ID: 27771499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer characteristics in very young Egyptian women ≤35 years.
    Farouk O; Ebrahim MA; Senbel A; Emarah Z; Abozeed W; Seisa MO; Mackisack S; Abdel Jalil S; Abdelhady S
    Breast Cancer (Dove Med Press); 2016; 8():53-8. PubMed ID: 27103842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trastuzumab and survival of patients with metastatic breast cancer.
    Kast K; Schoffer O; Link T; Forberger A; Petzold A; Niedostatek A; Werner C; Klug SJ; Werner A; Gatzweiler A; Richter B; Baretton G; Wimberger P
    Arch Gynecol Obstet; 2017 Aug; 296(2):303-312. PubMed ID: 28616827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis.
    Sanpaolo P; Barbieri V; Pedicini P; Fusco V
    Med Oncol; 2012 Jun; 29(2):459-65. PubMed ID: 21359639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
    Zell JA; Tsang WY; Taylor TH; Mehta RS; Anton-Culver H
    Breast Cancer Res; 2009; 11(1):R9. PubMed ID: 19228416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.
    Doval DC; Sharma A; Sinha R; Kumar K; Dewan AK; Chaturvedi H; Batra U; Talwar V; Gupta SK; Singh S; Bhole V; Mehta A
    Asian Pac J Cancer Prev; 2015; 16(12):4959-64. PubMed ID: 26163622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer.
    Cicin I; Karagol H; Usta U; Sezer A; Uzunoglu S; Alas-Cosar R; Yetisyigit T; Uygun K
    Med Oncol; 2009; 26(3):335-43. PubMed ID: 19003545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of p53 Overexpression with Hormone Receptor Status and Triple Negative Breast Carcinoma.
    Qamar S; Khokhar MA; Farooq S; Ashraf S; Humayon WA; Rehman A
    J Coll Physicians Surg Pak; 2019 Feb; 29(2):164-167. PubMed ID: 30700357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and prognostic factors of breast cancer with liver metastases.
    Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
    BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.